为在亚洲引入和推广长效艾滋病毒暴露前预防措施做好更充分的准备。

IF 1.8 4区医学 Q3 INFECTIOUS DISEASES

Sexual health Pub Date : 2024-06-01 DOI:10.1071/SH23192

Benjamin R Bavinton, Heather-Marie A Schmidt, Stephen Mills, Nittaya Phanuphak

{"title":"为在亚洲引入和推广长效艾滋病毒暴露前预防措施做好更充分的准备。","authors":"Benjamin R Bavinton, Heather-Marie A Schmidt, Stephen Mills, Nittaya Phanuphak","doi":"10.1071/SH23192","DOIUrl":null,"url":null,"abstract":"Long-acting injectable PrEP, particularly cabotegravir (CAB-LA), has the potential to enhance HIV prevention in Asia, and was the topic of a roundtable held in Singapore in June 2023. Despite proven efficacy, CAB-LA's impact in Asia is hindered by regulatory, manufacturing, and cost barriers. There is an urgent need to address these challenges to expedite CAB-LA's introduction and scale-up, including collaborative research, streamlined regulatory processes, and increased manufacturing capacity. We call for better preparedness in long-acting PrEP in research and implementation science, product licensing and accessibility, and capacity readiness for scale-up, to meet the significant demand among key populations in Asia.","PeriodicalId":22165,"journal":{"name":"Sexual health","volume":"21 ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving preparedness for introducing and scaling up long-acting HIV pre-exposure prophylaxis in Asia.\",\"authors\":\"Benjamin R Bavinton, Heather-Marie A Schmidt, Stephen Mills, Nittaya Phanuphak\",\"doi\":\"10.1071/SH23192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Long-acting injectable PrEP, particularly cabotegravir (CAB-LA), has the potential to enhance HIV prevention in Asia, and was the topic of a roundtable held in Singapore in June 2023. Despite proven efficacy, CAB-LA's impact in Asia is hindered by regulatory, manufacturing, and cost barriers. There is an urgent need to address these challenges to expedite CAB-LA's introduction and scale-up, including collaborative research, streamlined regulatory processes, and increased manufacturing capacity. We call for better preparedness in long-acting PrEP in research and implementation science, product licensing and accessibility, and capacity readiness for scale-up, to meet the significant demand among key populations in Asia.\",\"PeriodicalId\":22165,\"journal\":{\"name\":\"Sexual health\",\"volume\":\"21 \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sexual health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1071/SH23192\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1071/SH23192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

长效注射 PrEP，尤其是卡博替拉韦（CAB-LA），具有在亚洲加强艾滋病预防的潜力，这也是 2023 年 6 月在新加坡举行的圆桌会议的主题。尽管疗效已得到证实，但 CAB-LA 在亚洲的影响却受到监管、生产和成本障碍的阻碍。迫切需要应对这些挑战，以加快 CAB-LA 的引进和推广，包括合作研究、简化监管流程和提高制造能力。我们呼吁在长效 PrEP 的研究和实施科学、产品许可和可及性以及推广能力方面做好更充分的准备，以满足亚洲关键人群的巨大需求。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Improving preparedness for introducing and scaling up long-acting HIV pre-exposure prophylaxis in Asia.

Long-acting injectable PrEP, particularly cabotegravir (CAB-LA), has the potential to enhance HIV prevention in Asia, and was the topic of a roundtable held in Singapore in June 2023. Despite proven efficacy, CAB-LA's impact in Asia is hindered by regulatory, manufacturing, and cost barriers. There is an urgent need to address these challenges to expedite CAB-LA's introduction and scale-up, including collaborative research, streamlined regulatory processes, and increased manufacturing capacity. We call for better preparedness in long-acting PrEP in research and implementation science, product licensing and accessibility, and capacity readiness for scale-up, to meet the significant demand among key populations in Asia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Sexual health 医学-传染病学

CiteScore

2.30

自引率

12.50%

发文量

121

审稿时长

6-12 weeks

期刊介绍： Sexual Health publishes original and significant contributions to the fields of sexual health including HIV/AIDS, Sexually transmissible infections, issues of sexuality and relevant areas of reproductive health. This journal is directed towards those working in sexual health as clinicians, public health practitioners, researchers in behavioural, clinical, laboratory, public health or social, sciences. The journal publishes peer reviewed original research, editorials, review articles, topical debates, case reports and critical correspondence. Officially sponsored by: The Australasian Chapter of Sexual Health Medicine of RACP Sexual Health Society of Queensland Sexual Health is the official journal of the International Union against Sexually Transmitted Infections (IUSTI), Asia-Pacific, and the Asia-Oceania Federation of Sexology.